COLRF (Tian An Medicare) EV-to-EBITDA: 46.79 (As of Aug. 01, 2026) — 106% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

COLRF Tian An Medicare Ltd COLRF
43 GF Score
Price $0.08
GF Value $0.07
! 4 Warning Signs
View Full Analysis

What is Tian An Medicare EV-to-EBITDA?

Tian An Medicare COLRF 43 EV-to-EBITDA is 46.79 as of Aug. 01, 2026, which is 106% above its 10-year median of 22.73. GuruFocus rates COLRF with a GF Score™ of 43/100 and a GF Value™ of $0.07. The stock has 4 warning signs investors should review. Among 509 Healthcare Providers & Services companies, Tian An Medicare ranks worse than 90.37% on this metric.

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Tian An Medicare's enterprise value is $129.9 Mil. Tian An Medicare's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was $2.8 Mil. Therefore, Tian An Medicare's EV-to-EBITDA for today is 46.79.

The historical rank and industry rank for Tian An Medicare's EV-to-EBITDA or its related term are showing as below:

COLRF' s EV-to-EBITDA Range Over the Past 10 Years
Min: -12.03   Med: 22.73   Max: 91.15
Current: 46.5

During the past 13 years, the highest EV-to-EBITDA of Tian An Medicare was 91.15. The lowest was -12.03. And the median was 22.73.

COLRF's EV-to-EBITDA is ranked worse than
90.37% of 509 companies
in the Healthcare Providers & Services industry
Industry Median: 11.04 vs COLRF: 46.50

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2026-08-01), Tian An Medicare's stock price is $0.08. Tian An Medicare's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $-0.004. Therefore, Tian An Medicare's PE Ratio (TTM) for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


Tian An Medicare  (OTCPK:COLRF) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Tian An Medicare's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.08/-0.004
=At Loss

Tian An Medicare's share price for today is $0.08.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Tian An Medicare's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $-0.004.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


Tian An Medicare EV-to-EBITDA Related Terms


Tian An Medicare EV-to-EBITDA Historical Data

* Premium members only.

The historical data trend for Tian An Medicare's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tian An Medicare EV-to-EBITDA Chart

Tian An Medicare Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 26.61 26.20 4.60 4.44 11.38

Tian An Medicare Semi-Annual Data
Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.60 0.00 4.44 0.00 11.38

COLRF vs HCA, THC, DVA: EV-to-EBITDA Comparison

For the Medical Care Facilities subindustry, Tian An Medicare's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tian An Medicare EV-to-EBITDA vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Tian An Medicare's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Tian An Medicare's EV-to-EBITDA falls into.


COLRF
43GF Score
Tian An Medicare Ltd COLRF
EV-to-EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tian An Medicare EV-to-EBITDA Calculation

Tian An Medicare's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=129.877/2.776
=46.79

Tian An Medicare's current Enterprise Value is $129.9 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Tian An Medicare's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was $2.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EV-to-EBITDA →
What does a EV-to-EBITDA of 46.79 mean?
Tian An Medicare (COLRF) has a EV-to-EBITDA of 46.79 as of Aug. 01, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Tian An Medicare. This is 106% above median its historical median of 22.73. According to the industry distribution chart, Tian An Medicare ranks #460 out of 509 companies in the Healthcare Providers & Services industry, placing it in the top 90.4%.
Is Tian An Medicare's EV-to-EBITDA too high?
Tian An Medicare's current EV-to-EBITDA of 46.79 is 106% above median its 10-year median of 22.73. The Healthcare Providers & Services industry median EV-to-EBITDA is 11.04. Tian An Medicare's value of 46.79 is 323.8% above this industry median. Based on the distribution chart, Tian An Medicare ranks #460 out of 509 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Tian An Medicare has a GF Score™ of 43/100, reflecting its overall financial health beyond just this single metric.
How does Tian An Medicare's EV-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Tian An Medicare ranks #460 out of 509 companies for EV-to-EBITDA. This places Tian An Medicare in the lower half of its industry. The industry median EV-to-EBITDA is 11.04. Tian An Medicare's value of 46.79 is 323.8% above this benchmark. While the company's 10-year median is 22.73 vs. the industry median of 11.04, Tian An Medicare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 11.04, based on 509 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tian An Medicare's current EV-to-EBITDA of 46.79 is 323.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Tian An Medicare. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 11.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tian An Medicare's current EV-to-EBITDA is 46.79, which is 106% above median its own 10-year median of 22.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tian An Medicare stock overvalued right now?
Tian An Medicare (COLRF) has a current EV-to-EBITDA of 46.79. The stock's GF Value™ is $0.07, compared to a current price of $0.08 — trading 14.3% above its estimated fair value. The current EV-to-EBITDA is 46.79, which is 106% above median its 10-year median of 22.73 and 323.8% above the Healthcare Providers & Services industry median of 11.04. Tian An Medicare's overall GF Score™ is 43/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Tian An Medicare (COLRF), the current EV-to-EBITDA is 46.79 as of Aug. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tian An Medicare (COLRF) Overvalued in 2026?

Based on GuruFocus' analysis, Tian An Medicare stock appears to be overvalued. The current stock price of $0.08 is trading 14.3% above its estimated GF Value™ of $0.07.

Key valuation signals for COLRF:

  • EV-to-EBITDA: 46.79 (106% above median its 10-year median of 22.73)
  • GF Value™: $0.07 vs. price of $0.08 (14.3% above fair value)
  • GF Score™: 43/100 with 4 warning signs
  • Industry Position: 323.8% above the Healthcare Providers & Services median (#460 of 509)

No single metric tells the full story. See the COLRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Tian An Medicare Business Description

Other Exchanges 00383:Hong KongSMI:Germany
Address No. 138 Gloucester Road, Rooms 1904B-5, 19th Floor, Allied Kajima Building, Wanchai, Hong Kong, HKG
Tian An Medicare Ltd is an investment holding company and operator of integrated healthcare and eldercare services. Its main focus is on the investment, management and operations of healthcare and eldercare businesses, and the related property investment and development, and comprehensive spectrum of healthcare and eldercare services to customers in the People's Republic of China (PRC) and Asia Pacific. The Group is also involved in businesses of securities trading and investment, and provision of financial services. Its segments includes: Healthcare; Eldercare; and Property Development, of which it derives maximum revenue from Healthcare segment.
43GF Score

Get the complete analysis for COLRF

EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.08
Price
$0.07
GF Value